Swiss National Bank Generation Bio Co. Transaction History

Swiss National Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$3.66 - $6.77 $22,326 - $41,297	6,100 Added 6.06%	106,800 $419,000
Q2 2022 Aug 09, 2022	BUY	$4.87 - $9.41 $64,771 - $125,153	13,300 Added 15.22%	100,700 $661,000
Q1 2022 May 09, 2022	BUY	$4.16 - $7.76 $24,960 - $46,560	6,000 Added 7.37%	87,400 $642,000
Q3 2021 Nov 08, 2021	BUY	$20.0 - $27.43 $32,000 - $43,888	1,600 Added 2.01%	81,400 $2.04 Million
Q2 2021 Aug 06, 2021	BUY	$24.34 - $38.34 $238,532 - $375,732	9,800 Added 14.0%	79,800 $2.15 Million
Q1 2021 May 07, 2021	BUY	$24.74 - $40.2 $1.08 Million - $1.76 Million	43,800 Added 167.18%	70,000 $1.99 Million
Q4 2020 Feb 05, 2021	BUY	$21.68 - $51.61 $568,016 - $1.35 Million	26,200 New	26,200 $743,000

49.6M

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $54.9M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.